Previous Article | Next Article ![]()
Infection and Immunity, November 2001, p. 7162-7164, Vol. 69, No. 11
Department of Microbiology, Immunology, and
Parasitology, Louisiana State University Health Sciences Center,
New Orleans, Louisiana 70112,1 and
Immunobiology Vaccine Center, Medical Center, The
University of Alabama at Birmingham, Birmingham, Alabama
352942
Received 28 March 2001/Returned for modification 10 May
2001/Accepted 8 August 2001
Conditions consistent with tolerance or immunoregulation
have been observed in experimental Candida albicans
vaginal infections. The present study investigated the role of Recurrent vulvovaginal candidiasis,
caused predominantly by Candida albicans, is an
opportunistic fungal infection affecting an estimated 5 to 10% of
otherwise healthy women of childbearing age (20).
Cell-mediated immunity (CMI) involving Th1-type We and others have shown that vagina-associated T cells are
phenotypically distinct from those in the periphery, with high percentages of To assess the role of
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.7162-7164.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Resistance of T-Cell Receptor
-Chain-Deficient
Mice to Experimental Candida
albicans Vaginitis
![]()
ABSTRACT
Top
Abstract
Text
References
/
T cells in experimental vaginal candidiasis. Results showed that T-cell
receptor
-chain-knockout mice had significantly less vaginal fungal
burden when compared to wild-type mice, suggesting an
immunoregulatory role for
/
T cells in Candida vaginitis.
![]()
TEXT
Top
Abstract
Text
References
/
T-cell-receptor-positive (TCR+)
CD4+ T cells is the predominant host defense
mechanism against C. albicans at mucosal surfaces (1,
18). However, studies of women with recurrent vulvovaginal
candidiasis and an experimental murine model of vaginal candidiasis
show little if any protective role for systemic and mucosal CMI
(3, 4, 6, 7). Together, these results suggested that some
form of tolerance or immunoregulation inhibits more profound CMI
against vaginal candidiasis.
/
TCR+ T cells compared to
those in the periphery (8, 10, 11, 16). The purpose of the
current study was to more clearly define the role of
/
TCR+ T cells in immunity to experimental vaginal
candidiasis using TCR 
/
mice that are
homozygous for the Tcrdtm/MomC mutation
and consequently deficient in
/
T cells in all adult lymphoid and
epithelial organs (12).
/
TCR+ T cells in the
host response to experimental vaginal candidiasis, female TCR

/
mice (C57BL/6 background)
(9) and wild-type mice (Jackson Laboratory, Bar Harbor,
Maine), 8 to 12 weeks of age, were vaginally inoculated with
stationary-phase C. albicans 3153A blastoconidia as
previously described (5). Quantitative culture of vaginal lavage fluid demonstrated that the vaginal fungal burden in TCR 
/
mice was significantly less than in
wild-type mice (Fig. 1)
(P < 0.05 and 0.001 on days 4 and 10, respectively).
This suggested that the presence of
/
TCR+
T cells increased the susceptibility of mice to experimental C. albicans vaginitis. To identify a systemic immune correlate for
the resistance of TCR 
/
mice to
experimental C. albicans vaginitis,
Candida-specific delayed-type hypersensitivity (DTH)
was measured as previously reported (5). Results
showed that DTH values for TCR 
/
and
wild-type mice were similarly positive on day 10 postinoculation (0.312 ± 0.09 mm and 0.25 ± 0.06 mm, respectively) and
negative on day 4, consistent with the development of
Candida-specific DTH following infection (5).
Thus,
/
TCR+ T cells have no demonstrable
influence on Candida-specific DTH and DTH could not explain
the observed infection results.

View larger version (11K):
[in a new window]
FIG. 1.
Experimental vaginal candidiasis in the absence of
/
TCR+ T cells. Groups of 10 estrogen-treated TCR

/
and wild-type C57BL/6 mice were inoculated
vaginally with 5 × 104 C. albicans
blastoconidia. Mice were sacrificed on days 4 and 10 postinoculation,
and vaginal fungal burden was quantified by culture of vaginal lavage
fluid. Data are mean numbers of CFU (103) ± standard
errors of the means (SEM) for four experiments. *, P < 0.05; **, P < 0.0001.
In studies examining local cellular changes during infection, flow
cytometric analysis performed as previously described (8) showed no significant changes in the percentages of vaginal
CD4+ or CD8+
/
TCR+ cells in TCR 
/
mice compared to those in wild-type mice on days 4 and 10 postinoculation. As a confirmation, vaginal tissue sections prepared
from TCR 
/
and wild-type mice on day 10 postinoculation and stained with hematoxylin and eosin (H&E) (Hema-3
staining kit; Fisher Scientific, Pittsburgh, Pa.) showed no evidence of
a leukocyte infiltrate or any changes in the local cellular composition
as a result of infection (Fig. 2).
|
Local immunity was evaluated by the presence of Th1-type (gamma
interferon and interleukin-12 [IL-12]) and Th2-type (IL-4, IL-10, and
transforming growth factor
1) cytokines in
infected TCR 
/
and wild-type mice by
enzyme-linked immunosorbent assay (BD Pharmingen or Genzyme
Diagnostics, Cambridge, Mass) with concentrations normalized to total
protein (BCA kit; Pierce, Rockford, Ill.) as previously described
(22). Although cytokines were detected throughout infection as per previous studies (22), including high
concentrations of transforming growth factor
1
suggestive of local immunoregulation, no differences in vaginal
cytokine concentrations were observed between groups on days 4 and 10 postinoculation to explain the increased resistance of TCR

/
mice to infection (data not shown).
As local CMI did not reveal any correlates for the increased resistance
of TCR 
/
mice to C. albicans
vaginal infection, we next examined Candida-specific antibodies in vaginal lavages (pooled from 8 to12 animals per group)
collected from TCR 
/
and wild-type mice by
enzyme-linked immunosorbent assay using Candida soluble
cytoplasmic substances as the capture antigen as described elsewhere
(L. Cárdenas-Freytag, C. Steele, F. L. Wormley, Jr., E. Cheng, J. D. Clements, and P. L. Fidel, Jr., submitted for
publication). On days 4 and 10 postinoculation negligible levels of vaginal Candida-specific immunoglobulin G (IgG)
and IgA were detected in both groups of mice (data not shown).
Interestingly, a similar lack of Candida-specific IgG and
IgA was observed in CBA/J mice both during a primary vaginal infection
(unpublished results) and following mucosal immunization with
Candida antigen and the mucosal adjuvant LT(R192G)
(Cárdenas-Freytag et al., submitted).
We also examined mechanisms of innate resistance. Vaginal epithelial
cells from uninfected mice have been shown to inhibit the growth of
C. albicans in vitro (21). Vaginal epithelial cells from TCR 
/
and wild-type mice were
similarly capable of inhibiting the growth of C. albicans 50 to 65% at an effector-to-target (epithelial cell to C. albicans) ratio of 80:1 (data not shown), consistent with previous
results obtained with CBA/J mice (21). We also investigated the presence of NO2 in vaginal
tissue homogenates of infected mice using the Griess technique
(19), based on the nitric oxide-dependent candidicidal
activity of macrophages (13). Results showed that
NO2 levels in vaginal homogenates were similar between TCR 
/
and
wild-type mice on days 4 (18.2 ± 1.4 and 23.5 ± 2.2 µmol/mg of protein in TCR 
/
and
wild-type mice, respectively) and 10 (29.7 ± 3.4 and 23.6 ± 2.1 µmol/mg of protein in TCR 
/
and
wild-type mice, respectively) postinoculation. Thus, the enhanced
resistance to infection in the absence of
/
TCR+ T cells did not appear to be associated with
vaginal epithelial cell-mediated anti-Candida activity or
NO2 production.
The results of this study suggesting an immunoregulatory role for
/
TCR+ T cells leading to exacerbation of
infections is supported by other models of experimental
Salmonella enterica serovar Choleraesuis (2) and Listeria monocytogenes
(17) infection. Although resistance to lethal infection
with Salmonella enterica serovar Choleraesuis was associated
with a reduced inflammatory response, like in the present study, the
mechanism for resistance to L. monocytogenes is yet to be
elucidated. In contrast, the findings herein are contrary to the
increased susceptibility to infection observed in other experimental
models (14, 15) and to the increased susceptibility to
experimental vaginal Candida infection in mice depleted of
/
TCR+ T cells observed in a study using
complement-fixing antibodies (13). In the latter study,
however, depletion of vaginal
/
TCR+ T
cells was not confirmed. Although the mechanism by which
/
TCR+ T cells increase susceptibility to infection
is unknown, the resistance observed was consistent and reproducible.
Thus, it appears that
/
TCR+ T cells are
involved in some form of tolerance or immunoregulation inhibiting a more profound response to C. albicans at
the vaginal mucosa. Additionally, this immunoregulatory role appears to
be at both innate and adaptive levels since the effects were seen at
days 4 and 10 postinoculation. An immunoregulatory role would be
important to the survival of this vaginal commensal organism and
benefit the host as well by the limited inflammatory response upon
exposure to Candida. While
/
TCR+ T cells are not abundant at the vaginal
mucosa, their high percentage of total cells compared to that in the
periphery (8), as well as their unique TCR variable
gene segments (V
4V
1) (11), may be important to their site-specific immunoregulatory role.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grant AI 32556 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, 1901 Perdido St., New Orleans, LA 70112-1393. Phone: (504) 568-4066. Fax: (504) 568-4066. E-mail: pfidel{at}lsuhsc.edu.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288[Medline]. |
| 2. |
Emoto, M.,
H. Nishimura,
T. Sakai,
K. Hiromatsu,
H. Gomi,
S. Itohara, and Y. Yoshikai.
1995.
Mice deficient in ![]() T cells are resistant to lethal infection with Salmonella choleraesuis.
Infect. Immun.
63:3736-3738[Medline].
|
| 3. | Fidel, P. L., Jr., J. L. Cutright, and J. D. Sobel. 1995. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect. Immun. 63:4191-4194[Abstract]. |
| 4. | Fidel, P. L., Jr., M. E. Lynch, D. H. Conaway, L. Tait, and J. D. Sobel. 1995. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63:547-553[Abstract]. |
| 5. |
Fidel, P. L., Jr.,
M. E. Lynch, and J. D. Sobel.
1993.
Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
Infect. Immun.
61:1990-1995 |
| 6. |
Fidel, P. L., Jr.,
M. E. Lynch, and J. D. Sobel.
1994.
Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
Infect. Immun.
62:1032-1038 |
| 7. | Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1995. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun. 63:2403-2408[Abstract]. |
| 8. | Fidel, P. L., Jr., N. A. Wolf, and M. A. KuKuruga. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun. 64:3793-3799[Abstract]. |
| 9. |
Fujihashi, K.,
J. R. McGhee,
M. N. Kweon,
M. D. Cooper,
S. Tonegawa,
I. Takahashi,
T. Hiroi,
J. Mestecky, and H. Kiyono.
1996.
gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.
J. Exp. Med
183:1929-1935 |
| 10. |
Ibraghimov, A. R.,
R. E. Sacco,
M. Sandor,
Z. Iakoubov, and R. G. Lynch.
1995.
Resident CD4+ ![]() T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli.
Int. Immunol.
7:1763-1769 |
| 11. | Itohara, S., A. G. Farr, J. J. Lafaille, M. Bonneville, Y. Takagaki, W. Haas, and S. Tonegawa. 1990. Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature 343:754-757[CrossRef][Medline]. |
| 12. | Itohara, S., P. Mombaerts, J. Lafaille, J. Iacomini, A. Nelson, A. R. Clarke, M. L. Hooper, A. Farr, and S. Tonegawa. 1993. T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72:337-348[CrossRef][Medline]. |
| 13. |
Jones-Carson, J.,
A. Vazquez-Torres,
H. C. van der Heyde,
T. Warner,
R. D. Wagner, and E. Balish.
1995.
/ T cell-induced nitric oxide production enhances resistance to mucosal candidiasis.
Nat. Med.
1:552-557[CrossRef][Medline].
|
| 14. | Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, and S. H. Kaufmann. 1993. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 365:53-56[CrossRef][Medline]. |
| 15. |
Moore, T. A.,
B. B. Moore,
M. W. Newstead, and T. J. Standiford.
2000.
Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia.
J. Immunol.
165:2643-2650 |
| 16. | Nandi, D., and J. P. Allison. 1991. Phenotypic analysis and gamma/delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol. 147:1773-1778[Abstract]. |
| 17. |
O'Brien, R. L.,
X. Yin,
S. A. Huber,
K. Ikuta, and W. K. Born.
2000.
Depletion of a gammadelta T cell subset can increase host resistance to a bacterial infection.
J. Immunol.
165:6472-6479 |
| 18. | Odds, F. C. 1988. Candida and candidosis, p. 104-110. University Park Press, Baltimore, Md. |
| 19. |
Schwacha, M. G.,
J. J. Meissler, Jr., and T. K. Eisenstein.
1998.
Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.
Infect. Immun
66:5862-5866 |
| 20. | Sobel, J. D. 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 14:S148-S153. |
| 21. | Steele, C., H. Ozenci, W. Luo, M. Scott, and P. L. Fidel, Jr. 1999. Growth inhibition of Candida albicans by vaginal cells from naive mice. J. Med. Mycol. 37:251-260. |
| 22. | Taylor, B. N., M. Saavedra, and P. L. Fidel, Jr. 2000. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. J. Med. Mycol. 38:419-431. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|